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Nanomedicine is a booming medical field that utilises nanoparticles (NPs) for the development of medicines, medical 
devices, and diagnostic tools. The behaviour of NPs in vivo may be quite complex due to their interactions with biological 
molecules. These interactions in biological fluids result in NPs being enveloped by dynamic protein coronas, which serve 
as an interface between NPs and their environment (blood, cell, tissue). How will the corona interact with this environment 
will depend on the biological, chemical, and physical properties of NPs, the properties of the proteins that make the 
corona, as well as the biological environment. This review summarises the main characteristics of protein corona and 
describes its dynamic nature. It also presents the most common analytical methods to study the corona, including examples 
of protein corona composition for the most common NPs used in biomedicine. This knowledge is necessary to design 
NPs that will create a corona with a desired efficiency and safety in clinical use.
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Nanomedicine is a growing medical field that utilises 
nanomaterials for new applications in medicine, including 
their clinical use in disease diagnosis and treatment (1-3). 
According to the European Commission (4), 'Nanomaterial' 
means a natural, incidental or manufactured material 
containing particles, in an unbound state or as an aggregate 
or as an agglomerate and where, for 50 % or more of the 
particles in the number size distribution, one or more 
external dimensions is in the size range 1-100 nm. However, 
in medicine the term nanoparticle includes particles with 
dimensions of up to 1000 nm.
Due to a large surface-area-to-volume ratio, nanoparticles 
(NPs) have exceptional functional and structural properties 
that make them suitable to carry many diagnostic and 
therapeutic agents (5). Recent advances in nanomedicine 
have resulted in the development of biodegradable nanodrug 
delivery systems, nanocrystals for magnetic resonance 
imaging (MRI), and luminescent NPs for multiplexed 
molecular diagnostics (1, 3, 5, 6).
Because of the small size, NPs can enter almost every 
part of the body, including tissues, organs, and organelles 
(mitochondria, lysosomes, and endosomes) by different 
routes (e.g., inhalation, ingestion, injection, or physical 
contact with cuts or wounds) (2, 3, 7-9).
There are many types of NPs, including polymeric NPs, 
liposomes, carbon nanotubes, quantum dots, or metal-based 
NPs (gold, silver iron oxide, silica, titanium dioxide, etc.). 
Owing to the exceptional properties, these NPs may be used 
for targeted drug and contrast delivery, photothermal 
therapy, optical sensing, biochromatography, bioanalytical 
electrochemistry, biocidal agents and coatings, or a variety 
of bioassays (1-3, 5).
Their distribution, excretion, metabolism, and 
pharmacokinetics may be quite complex and pose a 
challenge for developing safe and effective nano-based 
biomedical agents. One of the key issues to resolve is rapid 
NP uptake and clearance by the reticuloendothelial system 
(RES), active vs. passive targeting, and penetration into 
tumour tissues (5).
Even though thousands of research papers have already 
been published on the interaction between NPs and 
biological systems, little is still known about the mechanistic 
details of these interactions (5). What are the biological 
interfaces that facilitate the interaction between NPs and 
cell components? This question should be addressed from 
the perspective of colloidal chemistry (10).
Blood as a biological medium contains more than a 
thousand biomolecules like proteins, lipids, and nucleic 
acids (1, 10). As soon as NPs enter the medium, ions, small 
molecules, proteins, and cells compete to adsorb on the NP 
surface due to its high reactivity (11). Plasma proteins have 
a critical role in creating nano-bio interfaces, as they 
opsonise NPs and form coronas (5, 12-16).
What kind of a protein corona forms around an NP's 
surface will depend on the NP's properties (size, shape, 
composition, surface functional groups, and surface 
charges), biophysical properties of the biological medium 
(blood, interstitial fluid, or cell cytoplasm), and the time of 
interaction. In other words, how will proteins adsorb on 
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NPs will depend not only on protein-NP interaction but also 
on protein-protein interactions.
Once formed, a protein corona will determine the 
physicochemical behaviour of an NP. Its properties are more 
important in determining the biological response 
(agglomeration, cellular uptake, circulation lifetime, 
signalling, kinetics, transport, accumulation, and toxicity) 
than NP's properties. In other words, to find out what will 
be the distribution, metabolism, and elimination of NPs in 
the body before it is applied in clinical practice, one needs 
to determine how protein corona affects them.
Knowing how to control the formation of the protein 
corona is crucial for most clinical uses of NPs (9, 10, 17, 
18). This review summarises the current knowledge on the 
nano-bio interface between NPs and proteins.
Dynamic nature of protein corona
When NPs come in contact with biological components, 
a nano-bio interface is formed. What makes it dynamic is 
a number of physicochemical interactions and 
thermodynamic exchanges between NP and biomolecular 
surfaces (7, 19-21). The dynamic nature of the nano-bio 
interface between NPs and proteins is best described by soft 
and hard coronas (Figure 1). Proteins with higher affinity 
for NP surface will exchange easily and quickly forming 
the hard corona, while proteins with low affinity exchange 
slowly forming the soft corona (19). The hard corona 
proteins interact directly with NP surface, while the soft 
corona proteins interact with the hard corona proteins via 
weak protein-protein interactions. The time needed for 
corona formation differs between the hard and soft corona. 
The hard corona is formed very quickly, within seconds or 
a minute, while the formation of the soft corona may take 
hours or even days, as proteins with higher affinity replace 
those with lower affinity (21). This process depends on 
protein concentrations and the composition of the biological 
environment.
Some suggest that even at low plasma concentrations, 
corona proteins will completely envelope the surface of an 
NP and modify its nature and physicochemical properties 
(19). Soft corona proteins can also interact with the hard 
corona proteins, as they desorb from NP surface and free 
the slot for other biomolecules to interact. All these 
exchanges are based on competitive adsorption and 
desorption of proteins, which depends on interaction time, 
protein concentrations, and their adsorption affinity for the 
NP. These exchanges, known as the Vroman effect (22, 23) 
have two stages. In the early stage, proteins adsorb rapidly 
with the highest association rates, and in the late stage 
proteins with short residence times are being replaced by 
proteins with slower association rates but longer residence 
times (24).
This dynamic nano-bio system is determined by 
hydrodynamic, electrostatic, electrodynamic, solvent, and 
steric interactions (Table 1) (25, 26).
This is why the nano-bio interface changes continuously 
in a biological environment (Figure 2), especially in the 
living cells, where different cell products are being secreted. 
When NPs move from one biological compartment to 
another, protein corona will change its profile. Some 
proteins form only transient complexes with NPs, while 
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Figure 1 Nano-bio interface: properties of protein corona on NP surface
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others will be tightly bound, depending on the specific NP 
type and the biological fluids in which NPs are suspended.
Protein adsorption on and interaction with NPs may 
induce conformational changes or crowding of proteins on 
the NPs surface or the formation of reactive oxygen species 
(ROS) that will cause oxidative damage to the adsorbed 
proteins (26). If a hydrophobic or charged protein sequence 
interacts with a hydrophobic or charged part of NP surface, 
this will induce thermodynamically favourable changes. 
Conformational changes of proteins induced by their 
interaction with NPs are typically irreversible (21) and may 
affect the downstream protein-protein interaction, cellular 
signalling, and DNA transcription, which directly affect 
enzyme activity (24). At the same time, protein binding that 
changes the shape, size, and surface charge of NPs will 
directly affect the agglomeration, cellular uptake, circulation 
lifetime, signalling, kinetics, transport, accumulation, and 
toxicity of NPs in a biological environment (10, 27).
A complex consisting of an NP and its protein corona 
is a new entity that cells can see (10, 28). For easier 
understanding, hard and soft coronas are usually presented 
as layers (Figure 1). The outer layer (soft corona) does not 
allow the inner layer (hard corona) to interact with the cell 
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Table 1 Main forces at the nano-bio interface (26)
Force Range (nm) Origin and properties
Hydrodynamic 
interactions 10
2-106
Long-range interactions; induced by particles moving in a viscous fluid, bulk 
transport, shear, lift, and Brownian diffusion; Increases the collision between NPs 
and other surfaces in the system
Electrostatic 
interactions 1-100
Coulomb interactions; induced by attraction or collision between charged 
interfaces and counter- or repel co-ions; characterized by the formation of an 
electrostatic double layer
Electrodynamic 
interactions 1-100
Van der Waals interactions that describe interactions between randomly oriented 
dipoles, between dipole and induced dipole, and fluctuating dipole and induced 
dipole
Solvent interactions 1-10 Interactions between lyophobic or lyophilic materials and solvent molecules
Steric interactions 1-100
Repulsive interactions with other interfaces; induced by adsorbed polymer layers 
on NPs surface; increase stability of individual NPs, but can interfere in cellular 
uptake
Figure 2 Changes in the structure and function of NPs and proteins caused by events occurring at the nano-bio interface [inspired by 
(10)]
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medium (6, 7, 11, 14, 18, 29). Of course, this will depend 
on the thickness of the outer layer.
Figure 3 shows the types of interactions between NPs 
and the biological medium. These interactions promote or 
inhibit: (a) the adsorption of ions, detergents, and other 
molecules from the medium, (b) attachment/detachment of 
proteins, (c) competitive binding, (d) steric hindrance on 
the NPs surface, (e) formation of two or more layers on NP 
surface, (e) NP dissolution and/or degradation, (f) surface 
reconstruction, and (g) accumulation and/or agglomeration 
of NPs (12, 27, 30, 31).
The most important physicochemical properties of an 
NP that define protein corona formation and fate are 
chemical composition, shape, curvature, surface 
functionalisation and structure, porosity, crystallinity, 
heterogeneity, roughness, and hydrophobicity/hydrophilicity 
(2-4). Furthermore, effective surface charge, aggregation 
state, stability, biodegradability, and dissolution properties 
of the NP surface layer are also important parameters that 
need to be considered for the investigation of the nano-bio 
interface (4, 32). For example, surface curvature of an NP 
affects protein-binding affinities. Greater curvature makes 
the corona thicker but decreases protein-protein interactions 
and conformational changes of the adsorbed proteins. 
Higher surface charge increases corona thickness as well 
as conformational changes of proteins (13, 27, 30, 31, 33). 
It may also trigger protein denaturation (27). Higher 
hydrophobicity increases corona thickness and 
conformational changes of proteins, as well as the 
opsonisation rate (14, 34).
All these properties and interactions (Figures 2-3) 
determine the long-range and short-range forces governing 
the nano-bio interface (Table 1) (10, 35). Long-range forces 
originate from attractive van der Waals and repulsive 
electrostatic double-layer interactions, while short-range 
forces arise from charge, steric interactions, depletion, and 
solvent interactions (Table 2) (10, 35).
Understanding how each physicochemical parameter 
of an NP affects corona formation is a key to designing new, 
efficient, and secure nanomaterials. Then these properties 
can be optimised, NPs pre-coated, and their surfaces 
functionalised to obtain the nature of the protein corona 
that would render an NP biocompatible (23). One should 
also take into account environmental factors, such as 
temperature, pH, protein concentrations, and time of 
interaction. NPs may also change adsorption, accumulation, 
degradation, agglomeration, dissolution, distribution, and 
clearance patterns after the protein corona has been formed, 
while the proteins forming the corona may pass through 
conformational changes, free energy release, restructuration, 
or change their binding profile and kinetics (10, 36, 37).
Mechanistic investigation of protein corona
The properties of metallic NPs can be investigated with 
a range of spectroscopic, electrophoretic, and microscopic 
methods (Table 2). The same methods can also be used to 
study protein corona formation and composition. The most 
common methods for determining NP properties are the 
transmission electron microscopy (TEM), light scattering 
techniques, and UV-visible and fluorescence spectroscopy. 
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Figure 3 Active interactions at the nano-bio interface [inspired by (10)]
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Newly synthesised metallic NPs are usually characterised 
in the medium used for their synthesis, such as water. 
Although quite demanding, NP evaluation in pure water is 
much less complicated than in any biological matrix.
Complexes that form between NPs and proteins are 
most often analysed with mass spectrometry (MS)-based 
proteomics. Spectroscopic methods like ultraviolet-visible 
(UV-Vis) and fluorescence spectroscopy, and circular 
dichroism (CD) are used to investigate nano-bio interface 
binding interactions due to their robustness and high 
sensitivity. UV-Vis spectroscopy can be used to measure 
the rate of protein binding as a function of change in 
plasmon λmax over time. Fluorescence spectroscopy acquires 
the intrinsic fluorescence of the protein and can therefore 
measure binding to NPs. CD spectroscopy uses changes in 
the chiral properties of a protein to predict changes in its 
secondary structure. Measured interactions between plasma 
proteins and NPs can be quantified using several kinetic 
models and equations (38-40). All the methods described 
in Table 2 are quite accessible and straightforward to 
evaluate nano-bio interface in pure water or a simple buffer 
system. In complex media like blood plasma or cellular 
matrix, however, analytical performance and interpretation 
of results may become very complex.
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Table 2 Analytical methods used to assess the of properties of NPs and their interactions at the nano-bio interface
NP properties Analytical technique Brief analytical description
Size and charge
light scattering (dynamic and 
electrophoretic)
changes in the hydrodynamic diameter of NP upon binding 
to proteins
analytical ultracentrifugation changes in the hydrodynamic diameter of NP
Size, shape and 
structure
transmission electron microscopy 
(TEM)
visualisation of NPs 
atomic force microscopy (AFM) visualisation of NPs
Structure X-ray diffraction determination of crystalline and chemical structure
Size, dissolution UV-Vis spectroscopy evaluation for surface plasmon resonance (SPR) peak
Dissolution, 
structure
inductively coupled plasma mass 
spectrometry (ICPMS)
determination of elemental composition 
Surface area Braunauer-Emmet-Teller method measurement of specific surface area using adsorption of 
gas on the surface
Protein binding 
affinity
fluorescence spectroscopy
evaluation of changes in fluorescence spectra of proteins 
due to the NPs-protein interaction
UV-Vis spectroscopy evaluation of changes in absorption spectra due to the NPs-protein interaction
isothermal calorimetry determination of binding constant, thermodynamic 
parameters of NP-protein interactions
quartz crystal balance determination of changes in mass at the oscillating quartz 
surface in the NPs-protein complexes
surface plasmon resonance
detection of change in oscillation of electrons on a metal 
surface in the NPs-protein complexes
AFM
determination of adhesion forces and surface free energy 
during the protein corona formation
fluorescence correlation 
spectroscopy
determination of binding characteristics depending on the 
fluctuation in florescence
Protein structural 
changes
circular dichroism spectroscopy measurement of changes in secondary structure of proteins 
depending on chiral properties of proteins
Fourier transformed infrared 
spectroscopy
measurement of adsorption of amide bonds in the proteins to 
derive structural change
Raman spectroscopy evaluation of molecular vibrations to predict structure
nuclear magnetic resonance determination of magnetic properties of atomic nuclei to predict structure
Composition of 
protein corona
capillary electrophoresis separation of proteins and NPs-protein complexes using very small sample volumes
LC-MS/MS
separation and identification of protein, accurate analysis of 
molecular weight (Mw) distribution
polyacrylamide gel electrophoresis 
(PAGE)
identification of proteins
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Table 3 Composition of protein corona by NP type
NP type Proteins detected in corona Reference
Polystyrene NPs
coagulation factors, immunoglobulins, lipoproteins, acute phase proteins, 
complement proteins, plasminogen, anti-CD4, c4a, albumin 1, 23,42
Latex NPs albumin, apolipoproteins, immunoglobulins, hemoglobin, haptoglobins 1, 23
Copolymer NPs albumin, apolipoprotiens, fibrinogen, immunoglobulins, C4BP-α-chain 1
Supraparamagnetic 
iron oxide NPs
albumin, α-1-antitrypsin, fibrinogen chains, immunoglobulin chains, transferrin, 
transthyretin 1, 41, 42
Gold NPs
albumin, fibrinogen chains, apolipoprotein A1, transport proteins, coagulation 
factors, tissue development proteins
1, 23, 42
Carbon nanotubes fibrinogen chains, immunoglobulin light chains, fibrin, albumin, ApoA1, 
complement, component proteins, fibronectin
1, 42
SiO2 NPs
immunoglobulins, lipoproteins, complement proteins, coagulation proteins, acute 
phase proteins, cell proteins, serum proteins 1, 23, 19
TiO2NPs, ZnONPs, 
SiO2 NPs
albumin, immunoglobulins, fibrinogen, transferrin, apolipoprotein A1, 
complement proteins, immunoglobulin light chains, fibrin, albumin, fibronectin
1, 23
Magnetic NPs albumin, apolipoprotein A1, complement factors, vitronectin, hemoglobin 1
Citrate-coated AgNPs
albumin, α-1-antiproteinase, α-2-HS-glycoprotein, apolipoprotein A1, 
serotransferrin, α-2-macroglobulin, α-fetoprotein, apolipoprotein B100, α-2-
antiplasmin, complement C3, β-2-glycoprotein 1, fetuin-B, inter-α-trypsin 
inhibitor heavy chain H1, hemoglobin foetal subunit β, inter-α-trypsin inhibitor 
heavy chain H3, inter-α-trypsin inhibitor heavy chain H2, hemoglobin subunit α, 
complement factor B, hemopexin, serpin A3-6
46
AgNPs coated with 
polyvinylpyrrolidone
albumin, α-2-HS-glycoprotein, α-1-antiproteinase, apolipoprotein A1, 
serotransferrin, α-2-macroglobulin, α-fetoprotein, apolipoprotein B100, 
complement C3, α-2-antiplasmin, inter-α-trypsin inhibitor heavy chain H1, 
fetuin-B, β-2-glycoprotein 1, hemoglobin foetal subunit beta, inter-α-trypsin 
inhibitor heavy chain H3, inter-α-trypsin inhibitor heavy chain H2, vitamin 
D-binding protein, transthyretin, hemoglobin subunit α, complement factor B
46
Protein corona composition
The most extensively studied biological environment 
for protein corona is human blood plasma. Protein layer(s) 
that adsorb on NPs in blood can affect their uptake and 
distribution in the cells. For example, fibrinogen, 
immunoglobulin G (IgG), or complement factors are 
believed to promote phagocytosis and removal of NPs from 
the bloodstream, while human serum albumin (HSA) and 
apolipoproteins prolong their circulation time in blood (19).
In the early stage of corona formation, albumin, IgG, 
fibrinogen, and apolipoproteins seem to adsorb rapidly on 
metallic NPs in plasma (13, 35, 41). These proteins are 
found in the hard coronas of all studied NPs and are replaced 
by apolipoproteins and coagulation factors in the slow phase 
of corona formation (35). Changes in biological environment 
also reflect on a corona composition. Walkey and Chan (21) 
use the term adsorbome to denote a group of 125 most 
common plasma proteins in the corona. Table 3 lists some 
of them by the type of NP.
Only two to six of them strongly adsorb on metallic 
NPs. For most metallic NPs, the corona is dominated by 
albumin (42), which is at the same time the most abundant 
protein in plasma. Although it has a negative net charge at 
pH 7.4, albumin contains 60 positively charged lysine 
residues, which enable its interaction with both positively 
and negatively charged NPs. Albumin will form anionic 
corona complexes with NPs regardless of their net charge 
(36). These coronas are similar in size and effective surface 
charge, but their behaviour in contact with the cell will 
differ. Fleischert and Payne (36) believe that cationic NPs 
alter the structure of albumin proteins in the corona, while 
anionic NPs do not. These structural changes affect the 
behaviour of the albumin-NP complex at the cellular level, 
so that cell receptors bind coronas formed around anionic 
NPs and redirect those formed around cationic NPs to 
scavenger receptors. Another difference is that albumin 
adsorbs much more on the surface of anionic than cationic 
NPs (23% vs. 8% of surface coverage, respectively) (36).
Similar to albumin, fibrinogen was also identified in the 
corona of many NPs. Apolipoproteins will mainly adsorb 
on liposomes and polymeric NPs, as they have low affinity 
for metallic NPs. The main force involved in their 
interactions with NPs is hydrophobicity (29). Polymeric 
and hydrophobic NPs also attract proteins like transferrin, 
haptoglobin, fetuin A, kininogen, histidine-rich glycoprotein, 
and intrinsic clotting pathway factors. Most of these proteins 
will adsorb on metallic NPs (29).
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Importance of protein corona for biomedical application 
of nanoparticles
As the NP-corona complex is actually “what the cell 
sees” (28), it is more important to determine the biological 
response (i.e., immunogenicity) to the complex than the 
properties of an NP alone (43). For most biomedical 
purposes, hard corona will likely improve the interaction 
between NPs and proteins, membranes, phospholipids, 
endocytic vesicles, organelles, and DNA (44-46).
Corona is what controls which type of biomolecule will 
it bind and how, how will the NP-corona complex interact 
with cells receptors, and what will its distribution and 
elimination be (45-46). For a nano-drug delivery system it 
is important to define the affinity, stoichiometry, kinetics, 
and the concentrations of NPs for their interaction with 
specific proteins. At the moment, however, we still have a 
lot to learn. The biggest challenge for researches is to find 
out how protein corona could contribute to nanodrug 
distribution in vivo.
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Kako proteinska korona određuje sudbinu nanočestica u biološkom okolišu
Nanomedicina je iznimno napredno medicinsko područje u kojem se iskorištavaju nanočestice za razvoj inovativnih 
lijekova, medicinskih pomagala i dijagnostičkih postupaka. U in vivo uvjetima ponašanje nanočestica može biti vrlo 
kompleksno zbog bliskih interakcija s biološkim molekulama. Zbog međudjelovanja nanočestica i proteina u biološkim 
tekućinama nastaje dinamička proteinska korona koja obavija nanočestice i tvori novo sučelje između nanočestica i okoliša 
u kojem se one nalaze (krv, stanice, tkiva). Ta međudjelovanja ovise o biološkim, kemijskim i fizikalnim svojstvima samih 
nanočestica i proteina, ali i samog biološkog okoliša. U ovom preglednom radu dan je prikaz glavnih karakteristika koji 
određuju proteinsku koronu te opis njezine dinamičke prirode. Prikazane su najvažnije analitičke metode za istraživanje 
proteinske korone te primjeri sastava proteinske korone za najčešće korištene vrste nanočestica u biomedicini. Takvo je 
znanje nužno za dizajn i razvoj učinkovitih i sigurnih nanomedicinskih proizvoda.
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